Consistently, the relative expression level of the lung fibrosis marker, TGF-β and α-SMA was elevated in the CS/LPS group relative to NC group, but this change was reversed in animals treated with roflumilast or either dose of GJT (Figure 6(B)). This evidence concerns the gene TGFB1 and pulmonary fibrosis.